[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cell and Advanced Therapies Supply Chain Management Market - Global Outlook and Forecast 2021-2027

April 2021 | 102 pages | ID: C541568124B5EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Cell and Advanced Therapies Supply Chain Management in Global, including the following market information:

Global Cell and Advanced Therapies Supply Chain Management Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Cell and Advanced Therapies Supply Chain Management market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell and Advanced Therapies Supply Chain Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cell and Advanced Therapies Supply Chain Management Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Cell and Advanced Therapies Supply Chain Management Market Segment Percentages, By Type, 2020 (%)
  • Cloud
  • On-premises
China Cell and Advanced Therapies Supply Chain Management Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Cell and Advanced Therapies Supply Chain Management Market Segment Percentages, By Application, 2020 (%)
  • Biobank
  • Cell Therapy Lab
  • Hospital
  • Research Institute
  • Commercial Organization
Global Cell and Advanced Therapies Supply Chain Management Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Cell and Advanced Therapies Supply Chain Management Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Cell and Advanced Therapies Supply Chain Management Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Cell and Advanced Therapies Supply Chain Management Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Be The Match BioTherapies
  • Brooks Life Sciences
  • Clarkston Consulting
  • Cryoport
  • Haemonetics
  • Hypertrust Patient Data Care
  • Lykan Bioscience
  • MAK-SYSTEM
  • MasterControl
  • SAP
  • SAVSU Technologies
  • sedApta Group
  • Stafa Cellular Therapy
  • Title21 Health Solutions
  • TraceLink
  • TrakCel
  • Vineti
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cell and Advanced Therapies Supply Chain Management Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cell and Advanced Therapies Supply Chain Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT OVERALL MARKET SIZE

2.1 Global Cell and Advanced Therapies Supply Chain Management Market Size: 2021 VS 2027
2.2 Global Cell and Advanced Therapies Supply Chain Management Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cell and Advanced Therapies Supply Chain Management Players in Global Market
3.2 Top Global Cell and Advanced Therapies Supply Chain Management Companies Ranked by Revenue
3.3 Global Cell and Advanced Therapies Supply Chain Management Revenue by Companies
3.4 Top 3 and Top 5 Cell and Advanced Therapies Supply Chain Management Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cell and Advanced Therapies Supply Chain Management Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell and Advanced Therapies Supply Chain Management Players in Global Market
  3.6.1 List of Global Tier 1 Cell and Advanced Therapies Supply Chain Management Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cell and Advanced Therapies Supply Chain Management Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Cell and Advanced Therapies Supply Chain Management Market Size Markets, 2021 & 2027
  4.1.2 Cloud
  4.1.3 On-premises
4.2 By Type - Global Cell and Advanced Therapies Supply Chain Management Revenue & Forecasts
  4.2.1 By Type - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2021
  4.2.2 By Type - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2022-2027
  4.2.3 By Type - Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cell and Advanced Therapies Supply Chain Management Market Size, 2021 & 2027
  5.1.2 Biobank
  5.1.3 Cell Therapy Lab
  5.1.4 Hospital
  5.1.5 Research Institute
  5.1.6 Commercial Organization
5.2 By Application - Global Cell and Advanced Therapies Supply Chain Management Revenue & Forecasts
  5.2.1 By Application - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2021
  5.2.2 By Application - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2022-2027
  5.2.3 By Application - Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Cell and Advanced Therapies Supply Chain Management Market Size, 2021 & 2027
6.2 By Region - Global Cell and Advanced Therapies Supply Chain Management Revenue & Forecasts
  6.2.1 By Region - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2021
  6.2.2 By Region - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2022-2027
  6.2.3 By Region - Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2027
  6.3.2 US Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.3.3 Canada Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.3.4 Mexico Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2027
  6.4.2 Germany Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.4.3 France Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.4.4 U.K. Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.4.5 Italy Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.4.6 Russia Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.4.7 Nordic Countries Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.4.8 Benelux Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2027
  6.5.2 China Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.5.3 Japan Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.5.4 South Korea Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.5.5 Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.5.6 India Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2027
  6.6.2 Brazil Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.6.3 Argentina Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2027
  6.7.2 Turkey Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.7.3 Israel Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.7.4 Saudi Arabia Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
  6.7.5 UAE Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Be The Match BioTherapies
  7.1.1 Be The Match BioTherapies Corporate Summary
  7.1.2 Be The Match BioTherapies Business Overview
  7.1.3 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.1.4 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.1.5 Be The Match BioTherapies Key News
7.2 Brooks Life Sciences
  7.2.1 Brooks Life Sciences Corporate Summary
  7.2.2 Brooks Life Sciences Business Overview
  7.2.3 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.2.4 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.2.5 Brooks Life Sciences Key News
7.3 Clarkston Consulting
  7.3.1 Clarkston Consulting Corporate Summary
  7.3.2 Clarkston Consulting Business Overview
  7.3.3 Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.3.4 Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.3.5 Clarkston Consulting Key News
7.4 Cryoport
  7.4.1 Cryoport Corporate Summary
  7.4.2 Cryoport Business Overview
  7.4.3 Cryoport Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.4.4 Cryoport Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.4.5 Cryoport Key News
7.5 Haemonetics
  7.5.1 Haemonetics Corporate Summary
  7.5.2 Haemonetics Business Overview
  7.5.3 Haemonetics Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.5.4 Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.5.5 Haemonetics Key News
7.6 Hypertrust Patient Data Care
  7.6.1 Hypertrust Patient Data Care Corporate Summary
  7.6.2 Hypertrust Patient Data Care Business Overview
  7.6.3 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.6.4 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.6.5 Hypertrust Patient Data Care Key News
7.7 Lykan Bioscience
  7.7.1 Lykan Bioscience Corporate Summary
  7.7.2 Lykan Bioscience Business Overview
  7.7.3 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.4.4 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.7.5 Lykan Bioscience Key News
7.8 MAK-SYSTEM
  7.8.1 MAK-SYSTEM Corporate Summary
  7.8.2 MAK-SYSTEM Business Overview
  7.8.3 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.8.4 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.8.5 MAK-SYSTEM Key News
7.9 MasterControl
  7.9.1 MasterControl Corporate Summary
  7.9.2 MasterControl Business Overview
  7.9.3 MasterControl Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.9.4 MasterControl Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.9.5 MasterControl Key News
7.10 SAP
  7.10.1 SAP Corporate Summary
  7.10.2 SAP Business Overview
  7.10.3 SAP Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.10.4 SAP Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.10.5 SAP Key News
7.11 SAVSU Technologies
  7.11.1 SAVSU Technologies Corporate Summary
  7.11.2 SAVSU Technologies Business Overview
  7.11.3 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.11.4 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.11.5 SAVSU Technologies Key News
7.12 sedApta Group
  7.12.1 sedApta Group Corporate Summary
  7.12.2 sedApta Group Business Overview
  7.12.3 sedApta Group Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.12.4 sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.12.5 sedApta Group Key News
7.13 Stafa Cellular Therapy
  7.13.1 Stafa Cellular Therapy Corporate Summary
  7.13.2 Stafa Cellular Therapy Business Overview
  7.13.3 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.13.4 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.13.5 Stafa Cellular Therapy Key News
7.14 Title21 Health Solutions
  7.14.1 Title21 Health Solutions Corporate Summary
  7.14.2 Title21 Health Solutions Business Overview
  7.14.3 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.14.4 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.14.5 Title21 Health Solutions Key News
7.15 TraceLink
  7.15.1 TraceLink Corporate Summary
  7.15.2 TraceLink Business Overview
  7.15.3 TraceLink Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.15.4 TraceLink Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.15.5 TraceLink Key News
7.16 TrakCel
  7.16.1 TrakCel Corporate Summary
  7.16.2 TrakCel Business Overview
  7.16.3 TrakCel Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.16.4 TrakCel Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.16.5 TrakCel Key News
7.17 Vineti
  7.17.1 Vineti Corporate Summary
  7.17.2 Vineti Business Overview
  7.17.3 Vineti Cell and Advanced Therapies Supply Chain Management Major Product Offerings
  7.17.4 Vineti Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
  7.17.5 Vineti Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Cell and Advanced Therapies Supply Chain Management Market Opportunities & Trends in Global Market
Table 2. Cell and Advanced Therapies Supply Chain Management Market Drivers in Global Market
Table 3. Cell and Advanced Therapies Supply Chain Management Market Restraints in Global Market
Table 4. Key Players of Cell and Advanced Therapies Supply Chain Management in Global Market
Table 5. Top Cell and Advanced Therapies Supply Chain Management Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cell and Advanced Therapies Supply Chain Management Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cell and Advanced Therapies Supply Chain Management Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cell and Advanced Therapies Supply Chain Management Product Type
Table 9. List of Global Tier 1 Cell and Advanced Therapies Supply Chain Management Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell and Advanced Therapies Supply Chain Management Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cell and Advanced Therapies Supply Chain Management Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cell and Advanced Therapies Supply Chain Management Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cell and Advanced Therapies Supply Chain Management Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cell and Advanced Therapies Supply Chain Management Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2022-2027
Table 30. Be The Match BioTherapies Corporate Summary
Table 31. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 32. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 33. Brooks Life Sciences Corporate Summary
Table 34. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 35. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 36. Clarkston Consulting Corporate Summary
Table 37. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 38. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 39. Cryoport Corporate Summary
Table 40. Cryoport Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 41. Cryoport Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 42. Haemonetics Corporate Summary
Table 43. Haemonetics Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 44. Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 45. Hypertrust Patient Data Care Corporate Summary
Table 46. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 47. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 48. Lykan Bioscience Corporate Summary
Table 49. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 50. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 51. MAK-SYSTEM Corporate Summary
Table 52. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 53. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 54. MasterControl Corporate Summary
Table 55. MasterControl Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 56. MasterControl Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 57. SAP Corporate Summary
Table 58. SAP Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 59. SAP Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 60. SAVSU Technologies Corporate Summary
Table 61. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 62. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 63. sedApta Group Corporate Summary
Table 64. sedApta Group Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 65. sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 66. Stafa Cellular Therapy Corporate Summary
Table 67. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 68. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 69. Title21 Health Solutions Corporate Summary
Table 70. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 71. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 72. TraceLink Corporate Summary
Table 73. TraceLink Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 74. TraceLink Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 75. TrakCel Corporate Summary
Table 76. TrakCel Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 77. TrakCel Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)
Table 78. Vineti Corporate Summary
Table 79. Vineti Cell and Advanced Therapies Supply Chain Management Product Offerings
Table 80. Vineti Cell and Advanced Therapies Supply Chain Management Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Cell and Advanced Therapies Supply Chain Management Segment by Type
Figure 2. Cell and Advanced Therapies Supply Chain Management Segment by Application
Figure 3. Global Cell and Advanced Therapies Supply Chain Management Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cell and Advanced Therapies Supply Chain Management Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell and Advanced Therapies Supply Chain Management Revenue in 2020
Figure 8. By Type - Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
Figure 12. US Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
Figure 16. Germany Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 17. France Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
Figure 24. China Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 28. India Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
Figure 30. Brazil Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
Figure 33. Turkey Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cell and Advanced Therapies Supply Chain Management Revenue, (US$, Mn), 2016-2027
Figure 37. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Cryoport Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. MasterControl Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. SAP Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. TraceLink Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. TrakCel Cell and Advanced Therapies Supply Chain Management Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications